# E-cigarette use, measured for the first time, emerged as a major concern at 17 percent, indicating a clear shift from ...

But it’s taking neither seriously. Despite the fact that more than 64% of people in the UK are either overweight or obese our ...

Improving access and affordability could be transformative for public health, given that about 88% of Americans are ...

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

A new study found that Ozempic's main ingredient may treat people with type 1 diabetes, control blood sugar, and lose weight.

A University of Dundee spin-out has formed a new company dedicated to developing new obesity therapies that avoid the muscle ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

Switzerland’s basic health insurance started reimbursing part of the cost of Wegovy, a weight-loss drug developed by Danish pharmaceutical giant Novo Nordisk. The decision has led to ...